Cost-of-illness studies: concepts, scopes, and methods

Liver diseases are one of the main causes of death, and their ever-increasing prevalence is threatening to cause significant damage both to individuals and society as a whole. This damage is especially serious for the economically active population in Korea. From the societal perspective, it is therefore necessary to consider the economic impacts associated with liver diseases, and identify interventions that can reduce the burden of these diseases. The cost-of-illness study is considered to be an essential evaluation technique in health care. By measuring and comparing the economic burdens of diseases to society, such studies can help health-care decision-makers to set up and prioritize health-care policies and interventions. Using economic theories, this paper introduces various study methods that are generally applicable to most disease cases for estimating the costs of illness associated with mortality, morbidity, disability, and other disease characteristics. It also presents concepts and scopes of costs along with different cost categories from different research perspectives in cost estimations. By discussing the epidemiological and economic grounds of the cost-of-illness study, the reported results represent useful information about several evaluation techniques at an advanced level, such as cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis.

[1]  M. Rayner,et al.  The economic burden of coronary heart disease in the UK , 2002, Heart.

[2]  K. Flegal,et al.  Methods of calculating deaths attributable to obesity. , 2004, American journal of epidemiology.

[3]  R. Kessler,et al.  Costs of attention deficit–hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000 , 2005, Current medical research and opinion.

[4]  L. Trupin,et al.  A national study of medical care expenditures for respiratory conditions , 2002, European Respiratory Journal.

[5]  M. Ryan Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. , 1999, Social science & medicine.

[6]  J Raftery,et al.  Perspectives in economic evaluation , 1998, BMJ.

[7]  Michael E. Chernew,et al.  Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  T. Hodgson The state of the art of cost-of-illness estimates. , 1983, Advances in health economics and health services research.

[9]  L L Kupper,et al.  Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, CT. , 1980, International journal of epidemiology.

[10]  Hodgson Ta The state of the art of cost-of-illness estimates. , 1983 .

[11]  R. Kessler,et al.  The economic burden of anxiety disorders in the 1990s. , 1999, The Journal of clinical psychiatry.

[12]  M. Drummond,et al.  Cost-of-illness studies: a major headache? , 1992, PharmacoEconomics.

[13]  Rice Dp Cost of illness studies: what is good about them? , 2000 .

[14]  M. Pauly Valuing health care: Valuing health care benefits in money terms , 1995 .

[15]  M. Johannesson,et al.  The friction cost method: a comment. , 1997, Journal of health economics.

[16]  J Benichou,et al.  A review of adjusted estimators of attributable risk , 2001, Statistical methods in medical research.

[17]  Ron Goeree,et al.  The Valuation of Productivity Costs Due to Premature Mortality: A Comparison of the Human-Capital and Friction-Cost Methods for Schizophrenia , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[18]  E. Finkelstein,et al.  National medical spending attributable to overweight and obesity: how much, and who's paying? , 2003, Health affairs.

[19]  P. Langley,et al.  A review of cost-of-illness studies on obesity. , 1998, Clinical therapeutics.

[20]  C. Weinberg,et al.  Use and misuse of population attributable fractions. , 1998, American journal of public health.

[21]  M. Reynaud,et al.  Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). , 2001, Alcohol and alcoholism.

[22]  M. Mugford,et al.  Elementary Economic Evaluation in Health Care , 1998 .

[23]  T. Hodgson,et al.  Cost-of-illness methodology: a guide to current practices and procedures. , 1982, The Milbank Memorial Fund quarterly. Health and society.

[24]  M A Koopmanschap,et al.  The friction cost method for measuring indirect costs of disease. , 1995, Journal of health economics.

[25]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[26]  T. Hodgson Costs of illness in cost-effectiveness analysis. A review of the methodology. , 1994, PharmacoEconomics.

[27]  D. Rice,et al.  Cost of illness studies: what is good about them? , 2000, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.

[28]  Ron Z. Goetzel,et al.  Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers , 2004, Journal of occupational and environmental medicine.

[29]  T. Hodgson,et al.  Medical care expenditures for diabetes, its chronic complications, and its comorbidities. , 1999, Preventive medicine.

[30]  V. Foster,et al.  Valuing the Multiple Impacts of Pesticide Use in the UK: A Contingent Ranking Approach , 2008 .

[31]  D. Pathak,et al.  Productivity-cost controversies in cost-effectiveness analysis: review and research agenda. , 1999, Clinical therapeutics.

[32]  A. Miners Estimating ‘Costs’ for Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[33]  E. Finkelstein,et al.  National medical expenditures attributable to overweight and obesity: How much and who's paying? , 2002 .

[34]  H. Birnbaum,et al.  Attention-deficit/hyperactivity disorder: increased costs for patients and their families. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  M. Ward,et al.  Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[36]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[37]  P. Zarembka Frontiers in econometrics , 1973 .

[38]  M. Drummond Cost-of-Illness Studies , 1992, PharmacoEconomics.

[39]  B. Bloom,et al.  Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making , 2012, PharmacoEconomics.

[40]  Frank A. Sloan,et al.  Valuing health care , 1996 .

[41]  C. Donaldson,et al.  Economics and obesity: costing the problem or evaluating solutions? , 2004, Obesity research.

[42]  L. Trupin,et al.  A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care. , 2001, Arthritis and rheumatism.

[43]  Per-Olov Johansson,et al.  Evaluating Health Risks: An Economic Approach , 1995 .

[44]  Rosanna Tarricone,et al.  Cost-of-illness analysis. What room in health economics? , 2006, Health policy.

[45]  H. Morgenstern,et al.  Measures of Disease Incidence Used in Epidemiologic Research , 1980 .

[46]  J. Mincer Investment in Human Capital and Personal Income Distribution , 1958, Journal of Political Economy.

[47]  F. Tediosi,et al.  Costs of diabetes. A methodological analysis of the literature. , 1999, PharmacoEconomics.